The study has unmasked that 2-deoxyD-ribose derived from myeloma cells promoted the expression of major histocompatibility complex class II transactivator (CIITA) in osteocytes through the STAT1/IRF1 signaling pathway. This evidence concerns the gene CIITA and plasma cell myeloma.